|TRUSTEES' REPORT INCORPORATING|TRUSTEES' REPORT INCORPORATING|THE STRATEGIC REPORT||
|---|---|---|---|
|INDEPENDENT AUDITOR'S REPORT|||.13|
|FINANCIAL STATEMENTS|||.15|
|NOTES TO THE ACCOUNTS|||.18|
|REFERENCE AND ADMINISTRATIVE|DETAILS||....33|
|The Board of|The Board of|Trustees|Trustees|is responsible
for ensuring
there are effective and adequate
risk management
and internal|is responsible
for ensuring
there are effective and adequate
risk management
and internal|is responsible
for ensuring
there are effective and adequate
risk management
and internal|is responsible
for ensuring
there are effective and adequate
risk management
and internal|is responsible
for ensuring
there are effective and adequate
risk management
and internal|is responsible
for ensuring
there are effective and adequate
risk management
and internal|
|---|---|---|---|---|---|---|---|---|---|
|control|systems||in place, and confirm that the major risks to which||||the|Institute
is exposed have been reviewed||
|and procedures|||established
to manage those risks. The Audit||and Risk Committee
agrees an annual
risk-based|||||
|internal|audit|plan which covers major risks identified
by management||||||and Trustees.
It receives reports from||
|internal|auditors||on the|effectiveness
of internal
controls, progress|||against the internal
audit plan and progress||on|
|recommendations|||made
in reports.
The Board reviews a full risk||||report annually,
including
a 'heat map' tracking|||
|major|risks.|||||||||
|The principal||risks and||uncertainties
facing the Institute are considered||||to be:||
|||||&BBSRCstrategic funding
for institutes
is||||&Regular monitoring
ofscientific||
|||||reduced due to budgetary
pressures.||||performance
against strategic||
|||||&BBSRCstrategic funding
is reduced due|to|||programme
objectives.||
|||||scientific performance.||||&Regular communication
with BBSRCto||
|||||||||report performance
and ensure strategic||
|||||||||alignment
ofresearch programmes.||
|||||& QIB is unable to generate
sufficient grant||and||& Investment
in new research
leader||
|||||commercial
research
income to support|the|||positions
in progress.||
|||||costs of its research activities and||||& Communication
Strategy being||
|||||infrastructure||||developed
to increase sponsor||
|||||||||awareness
ofthe Quadram
Institute.||
|||||& QIB is unable to retain or attract suitably||||&Strategy and action plans
in place,||
|||||skilled staff to enable
itto deliver its science||||aligned to development
of Quadram||
|||||strategy.||||Institute.||
|||||& In addition to scientific impact, this risk area||||&Career development
programmes
in||
|||||could also have an impact on the level of||||place to support
high potential
staff.||
|||||funding
the Institute
is able to attract.||||&Performance
Management
processes|in|
|||||||||place.||
|||||&Strategy for the Quadram
Institute
is not||||&Governance
arrangements
in place.||
|||||agreed between
the partners.||||&Strategy agreed and communicated.||
|||||&The Quadram
Institute
is not able to attract||||& Recruitment
plans
in progress.||
|||||suitably
skilled staff to enable
it to deliver||its||&Project plan
in place, with identified
work||
|||||strategy.||||streams, terms ofreference and||
|||||& Benefits from the project are not delivered.||||appropriate
partner representation.||
|||||||||&Project assurance
framework
in place.||
|||||& Ql facilities management
arrangements|are|||& Building Services Committee
established||
|||||poor value for money.||||to monitor facilities management||
|||||& Inadequate
investment
leads to facilities|that|||arrangements
and tenant coordination.||
|||||are not fit for purpose.||||& Building operating costs regularly||
|||||& Ql building
is not used by partners
in line with||||reviewed
and remedial
actions agreed.||
|||||Ql mission.||||& Lifecycle maintenance
plan agreed by||
|||||||||the partners.||
|||||& QIB is unable to keep pace with||||&Technology
strategy has been updated||
|||||developments
in technology
underpinning|||its|alongside
strategy for the Quadram||
|||||science.||||Institute.||
|||||& Funding
is inadequate
to sustain
and improve||||& Capital funding
awarded
for the period|to|
|||||technology
facilities necessary
to deliver||||March 2023as part of institute
strategic||
|||||scientific objectives.||||grant award.||
|||||& QIBfails to comply with sponsor grant||||&QIB is subject to regular reviews of its||
|||||requirements
resulting
in a material
financial||||grant compliance
processes from||
|||||impact.||||sponsors
and the internal
auditors.||
|||||& QIB is not able to access EU programme||||& Regular dialogue
with staff, BBSRC, EU||
|||||funding
or participate
in EU research||||partners
and other key stakeholders
on||
|||||collaborations.||||risks and emerging
issues with respect||
|||||& QIB is not able to recruit or retain||||to potential
changes
in arrangements.||
|||||researchers
from EU member countries.||||||
|||||& Loss of research
activity due to staff||||& Building has been reopened
subject to||
|||||becoming
ill, or not being able to attend|work|||strict H&S/risk management
protocols.||
|||||due to the COVID-19.||||&Business Continuity
Group established||
|||||& Loss of income or additional
costs incurred||||to implement
policies and oversee||
|||||as a result ofthe impact ofCovid-19 on||||arrangements.||
|||||activity.||||& UKRI funding
received to mitigate
impact||
|||||& Failure ofsu
I
chain.||||on
rants and studentshi
s.||
|The Board ofTrustees|comprises
an independent
Chair,|comprises
an independent
Chair,|comprises
an independent
Chair,|up|to seven|independent|independent|members|and up to nine UEA-|
|---|---|---|---|---|---|---|---|---|---|
|appointed
members.|The|Trustees who|served during
the year and|||up|to the date|of signing|these financial|
|statements
were:||||||||||
|Trustees||Sub-committees||||||Changes|during the period|
|At date ofReport:||||||||||
|Dr C Caulcott (Chair)||Remuneration|& Nomination|Committee||||||
|Dr E Blair||Audit 8 Risk|Committee;
Remuneration|||8||Appointed|14 May 2020|
|||Nomination
Committee||||||||
|Prof F Lettice||Science Innovation
8 Advisory|||Committee||(Chair)|||
|Prof P Morgan||Remuneration|& Nomination|Committee||(Chair)||||
|Mr G Potter||Audit & Risk|Committee|||||Appointed|14 May 2020|
|Dr E Robertson||Science Innovation
8 Advisory|||Committee|||Appointed|14 May 2020|
|Mrs J Waterfield||Audit & Risk|Committee
(Chair)|||||||
|Served during
the year:||||||||||
|Dr T Brears (Chair)||Remuneration|& Nomination|Committee||||Resigned|14 May 2020|
|Prof SWalker||Audit & Risk|Committee;
Remuneration|||&||Resigned|17June 2020|
|||Nomination
Committee||||||||
||||||Restricted|Restricted|||
|---|---|---|---|---|---|---|---|---|
|||||Unrestricted|general|capital|Total|Total|
|||||funds|funds|funds|2021|2020|
||||Note|FOOO|f000|FOOO|OOOO|f000|
|Incoming resources|||||||||
|Income from Charitable|activities||||||||
|Grant income|||||14,820||14,820|12,143|
|Capital and maintenance|grants||||3,243|2,826|6,069|1,302|
|Other charitable
income||||775|230||1,005|503|
|Income from other trading activities|||||||||
|Trading
income||||642||||798|
|Investment income||||195|||195|312|
|Total income|||2|1,612|18,293|2,826|22 731|15,058|
|Expenditure|||||||||
|Charitable
activities||||(662)|(17,557)|(981)|(19,200)|(15,547)|
|Raising funds||||(184)|—|—|(184)|(172)|
|Trading
expenditure||||(614)|||(614)|(711)|
|Total ex enditure|||3|1,460|17,557|981|19,998|16,430|
|Net incomel ex enditure||||152|736|1,845|2,733|1,372|
|Transfers|||||||||
|Capital transfers|||18|(603)||603|||
|Other transfers|||18|(2,178)|2,178||||
|Net movement
in funds|for the|ear||2,629|2,914|2,448|2 733|1,372|
|Funds brought forward|||18|31,150||4,191|35,341|36,713|
|Funds carried forward|||18|28,521|2,914|6,639|38074|35,341|
|||||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|---|---|---|
|||||||2021|2020|2021|2020|
||||||Note|f000|f000|f000|f000|
|Fixed assets||||||||||
|Tangible assets|||||9|19,078|18,364|19,078|18,363|
|Intangible
assets|||||10||12||12|
|Total fixed assets||||||19078|18,376|19078|18,375|
|Current assets||||||||||
|Debtors|||||12|9,632|6,508|9,584|6,519|
|Cash at bank and|in||hand||13|19,457|16,595|19,183|16,385|
|||||||29,089|23,103|28,767|22,904|
|Current
liabilities||||||||||
|Creditors: amounts||falling||due within one year|14|(10,093)|(6,102)|(9,796)|(5,989)|
|Total net current assets||||||18996|17,001|18971|16,915|
|Total assets less current||||liabilities||38,074|35,377|38,049|35,290|
|Provisions for liabilities|||and|charges|16||(36)||(36)|
|Total net assets|||||17|38074|35341|38049|35254|
|Funds ofthe charity||||||||||
|Unrestricted
funds||||||||||
|Fixed assets reserve|||||18|14,972|15,746|14,972|15,739|
|Designated
strategic|||reserves||18|6,486|6,921|6,486|6,921|
|Designated
building||reserves|||18|3,050|4,375|3,050|4,375|
|General reserve|||||18|4,013|4,108|3,988|4,022|
|Total unrestriced
funds||||||28,521|31,150|28,496|31,057|
|Restricted funds||||||||||
|Fixed assets reserve|||||18|4,106|2,630|4,106|2,636|
|Restricted
general|||||18|2,914||2,914||
|Capital reserve|||||18|2,533|1,561|2,533|1,561|
|Total restricted
funds||||||9,553|4,191|9,553|4,197|
|Total charit
funds|||||18|38074|35341|38049|35254|
##
|||||||||||Total|Total|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||2021|2020|
|||||||||||6000|f000|
|Cash flow from operating|activities|||||||||||
|Operating
surplus/(deficit)||||||||||2,733|(1,372)|
|Interest receivable||||||||||(195)|(312)|
|Depreciation
and amortisation||||||||||981|804|
|Capital grants received||||||||||(6,069)|(1,302)|
|Loss on disposal of tangible|assets|||||||||2|4|
|Decrease
in stocks|||||||||||32|
|Increase
in debtors||||||||||(4,099)|(561)|
|Increase
in creditors||||||||||3,991|1,846|
|Decrease
in provisions||||||||||(36)|(215)|
|Net cash
rovided b
/ used||in|o|ratin||activities||||2 692|1,076|
|Cash flow from investing|activities|||||||||||
|Interest received||||||||||195|312|
|Repayment
of loan||||||||||975|1,300|
|Purchase oftangible assets||||||||||(1,693)|(3,242)|
|Disposal Proceeds||||||||||8||
|Capital grants received||||||||||6,069|1,302|
|Net cash
rovided b
/ used||in|investin|||activities||||5554|328|
|Chan e in cash and cash|e|uivalents|||in|the re|ortin|cried||2 862|1 404|
|Cash and cash equivalents|at|the|beginning|||of the|reporbng|period|13|16,595|17,999|
|Cash and cash e uivalents||at theend|||of|there|ortin|eriod|13|19457|16595|
||||Research|Other|Total|Research|Other|Total|
|---|---|---|---|---|---|---|---|---|
||||activities|activities|2021|activities|activities|2020|
||||OOOO|f000|6000|f000|f000|6000|
|Grant income|||||||||
|BBSRC|||12,402||12,402|10,017||10,017|
|Other government
departments|||1,011||1,011|471||471|
|European
Union|||488||488|403||403|
|Other grants|||919||919|1,252||1,252|
|Total
rant income|||14820||14820|12143|0|12143|
|Capital and maintenance||grants|||||||
|BBSRC|||||||||
|Capital expenditure|||6,069||6,069|1,302||1,302|
|Total ca ital
rants|||6069||6069|1 302||1 302|
|Other charitable
income|||||||||
|Miscellaneous
income||||1,005|1,005||503|503|
|Total other charitable|income|||1,005|1 005||503|503|
|Trading
income|||||||||
|QIB Extra||||642|642||798|798|
|Total tradin
income||||642|642||798|798|
|Investment
income|||||||||
|Interest receivable
on cash||deposits||86|86||165|165|
|Other interest receivable||||109|109||147|147|
|Total investment
income||||195|195||312|312|
|Total incomin
resources|||20,889|1,842|22 731|13,445|1,613|15058|
||||||Research|Research|Student|Other|Total
Research|Total
Research|Student|Olher|Total|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||activities||activities|activities|2021|activities|activities|activities|2020|
|||||Note||EOOO|EOOO|OOOO|FOOO|EOOO|f000|FOOO|OOOO|
|Direct charitable|expenditure|||||||||||||
|Staff costs||||||7,146|||7,146|6,592|||6,592|
|Direct costs||||||5,130|546||5,676|2,651|490||3,141|
|Depreciation||||||981|||981|804|||804|
|Buildings
maintenace||||||348|||348|190|||190|
|Governance
costs||||||||36|36|||44|44|
|Support costs||||||4,759|254||5,013|4,534|242||4,776|
|Expenditure
on|charitable||activities|||18,364|800|36|19,200|14,771|732|44|15,547|
|Raising funds||||||||184|184|||172|172|
|Trading
expenditure||||||||614|614|||711|711|
|Total ex enditure||||||18364|800|834|19998|14,771|732|927|16430|
|Included
within||expenditure||on charitable|activities||is restricted|general|expenditure
ofF17,557k (2020:F12,482k), and|||||
|restricted
capital||expenditure||(depreciation)||ofF981k (2020:F804k). All|||other expenditure|is unrestricted.||||
|Operating
surplus/(deficit)
is s|tated afte|r charging|/(crediting):|||||||
|---|---|---|---|---|---|---|---|---|---|
|||||||||Total|Total|
|||||||||2021|2020|
|||||||||OOOO|f000|
|Auditservices:||||||||||
|Fees payable for the audit of the|charitable|company|and consolidated||financial||statements|22|22|
|Fees payable for the audit of the|charitable|company's|subsidiaries|pursuant||to|legislation|2|2|
|Depreciation||||||||981|804|
|Hire of plant and equipment||||||||18|48|
|Loss on disposal of tangible assets||||||||2|4|
|Loss/(Gain)
on foreign exchange|translations|||||||59|(21)|
|The average
follows:||monthly
number of persons employed
by or deployed
to the|group during the year, analysed|by category,|was as|
|---|---|---|---|---|---|
|Grou||||2021|2020|
|||||Number|Number|
|Scientific||||162|138|
|Office mana|ement and services|||20|29|
|Total||||182|167|
|The aggregate||payroll costs ofthese persons were:||||
|||||2021|2020|
||||Note|6000|L'000|
|Wages and|salaries|||6,480|5,982|
|Redundancy||payments||56|126|
|Social security costs||||683|620|
|Other
ension||costs|20|889|843|
|Total||||8 108|7,571|
|Grou
and charitable|com an|2021|2020|
|---|---|---|---|
|||Number|Number|
|F60,000 - F69,999||||
|F70,000 —F79,999||||
|F80,000 - F89,999||||
|F90,000 —F99,999||||
|F100,000 - L'109,999||||
|F110,000 —f119,999||||
|F120,000 - L'129,999||||
|F130,000 —8139,999||||
|Total||23|22|
||||Leasehold|Apparatus|Apparatus|Apparatus|Assets||
|---|---|---|---|---|---|---|---|---|
||||land and|||and|under||
|Grou|||buildin
s|e|ui|ment|construction|Total|
||||f000|||i'.000|f000|f000|
|Cost/Valuation|||||||||
|At 1 April 2020|||14,609||11,591||727|28,927|
|Transfer||||||649|(649)||
|Additions||||||225|1,468|1,693|
|Dis osals||||||525|10|535|
|At 31 March 2021|||14609||11940||1 538|28085|
|Accumulated|Depreciation||||||||
|At 1 April 2020|||240|||8,323||8,583|
|Charge for the|year||245|||724||969|
|Dis osals||||||525||525|
|At 31 March 2021|||485|||8522||9007|
|Net book value at 31 March 2021|||14124|||3418|1 536|19078|
|Net book value|at 31 March 2020||14,369|||3,268|727|18,364|
||||Leasehold|Apparatus|||Assets||
||||land and|||and|under||
|Charitable
com an|||buildin
s|e|ui|ment|construction|Total|
||||FOOO|||f000|f000|OOOO|
|Cost/Valuation|||||||||
|At 1 April 2020|||14,609||11,494||727|28,830|
|Transfer||||||649|(649)||
|Additions||||||225|1,468|1,693|
|Dis osals||||||525|10|535|
|At 31 March 2021|||14609||11843||1 536|27988|
|Accumulated|Depreciation||||||||
|At 1 April 2020|||240|||8,227||8,467|
|Charge for the|year||245|||723||968|
|Dis osals||||||525||525|
|At 31 March 2021|||485|||8425||8910|
|Net book value at 31 March 2021|||14124|||3418|1,536|19078|
|Net book value|at 31 March 2020||14,369|||3,267|727|18,363|
|All ofthe tangible assets ofthe charitable||company are used for charitable|purposes.||||||
|||Software|Software||
|---|---|---|---|---|
|Grou
and charitable|com an|develo|ment|Total|
||||f000|FOOO|
|Cost/Valuation|||||
|At 1 April 2020|||147|147|
|Additions|||||
|Dis osals|||||
|At 31 March 2021|||147|147|
|Accumulated
Depreciation|||||
|At 1 April 2020|||135|135|
|Charge for the year|||12|12|
|Dis osals|||||
|At 31 March 2021|||147|147|
|Net book value at 31|March 2021||||
|Net book value at 31 March 2020|||12|12|
|||Registration|Country of|||Class|and percentage|and percentage|of|
|---|---|---|---|---|---|---|---|---|---|
|Subsidiar|Undertakin|number|re istration|Principal|activit|shares|held|||
|QIB Extra|Limited|06500711|England|Contract|research|100%|ordinary|shares||
|IFREnterprises
Limited||03398534|England|Dormant||100%|ordinary|shares||
|IFR NRP|Capital
Limited|08132483|England|Dormant||100%|ordinary|shares||
|||||IFR|QIB|IFR NRP|||
|---|---|---|---|---|---|---|---|---|
|||||Enterprises|Extra|Capital|Total|Total|
|Profit and loss account||||Limited|Limited|Limited|2021|2020|
|||||f000|FOOO|f000|6000|FOOO|
|Turnover|||||646||646|808|
|Cost of sales|||||346||346|477|
|Gross profit|||||300||300|331|
|Administrative|e|enses|||268||268||
|0 eratin|refit|retained|in subsidia||32||32|97|
||||||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||2021|2020|2021|2020|
|||||||Note|f000|FOOO|f000|f000|
|Grants receivable:|||||||||||
|from government||bodies|||||3,477|548|3,477|548|
|from other sources|||||||1,521|963|1,521|963|
|Trade debtors|||||||322|84|211|11|
|Amounts
owed|by|subsidiary||undertakings|||||75|89|
|Amounts
owed|by|other|related parties|||21|3,524|4,347|3,524|4,346|
|Other debtors|||||||83|178|83|178|
|Pre a ments and||accrued||income|||705|388|693|384|
|Total amounts|fallin||due|within one|ear||9632|6 508|9584|6519|
||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|
||||2021|2020|2021|2020|
||||F000|f000|F000|f000|
|Cash|at|bank|19,454|16,593|19,180|16,383|
|Cash|in|hand|3|2|3|2|
|Total|||19457|16595|19183|16385|
||||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|---|---|
||||||2021|2020|2021|2020|
|||||Note|f000|FOOO|f000|f000|
|Grants received in advance:|||||||||
|from government
bodies|||||951|793|951|793|
|from other sources|||||2,332|1,485|2,179|1,473|
|Amounts
owed to subsidiary||undertakings|||||||
|Amounts
owed to other|related parties||||3,467|853|3,467|853|
|Trade creditors|||||425|498|419|486|
|Other creditors|||||1,415|1,106|1,415|1,100|
|Accruals and deferred|income||||1,342|1,206|1,204|1,123|
|Taxation and social securi|||||161|161|161|161|
|Total amounts
fallin|due|within one|ear||10093|6 102|9796|5989|
||||||||Total|Total|
|---|---|---|---|---|---|---|---|---|
|Grou|||||||2021|2020|
|||||||Note|f000|f000|
|Grants|receivable|||||12|4,998|1,511|
|Grants|received
in advance|||||14|3283|2,278|
|Net|rants received|in advance|||||1 715|767|
|Net grants received
in||advance|at beginning||ofyear||(767)|(872)|
|Grant|monies received|during|the year||||(13,343)|(12,541)|
|Grant|mone
released|to SOFA durin||the|ear||15825|12,646|
|Net|rants received|in advance at end of|||ear||1 715|767|
|||||Dilapidations|Total|Total|
|---|---|---|---|---|---|---|
|Group and charitable|||company|provision|2021|2020|
|||||FOOO|FOOO|FOOO|
|Provision||at beginning|ofyear|36|36|251|
|Charge|in|the year||(36)|(36)|(34)|
|Ulilised||||||181|
|Provision||at end of|ear|||36|
|||||||Creditors||
|---|---|---|---|---|---|---|---|
||||||Net|over one||
|||||Fixed|current|year and|Total|
|||||assets|assets|rovisions|2021|
|||||f000|f000|FOOO|FOOO|
|Group||||||||
|Unrestricted:||||||||
|Fixed assets||reserve||14,972|||14,972|
|Designated||strategic|reserve||6,486||6,486|
|Designated||building|reserve||3,050||3,050|
|General|||||4,013||4,013|
|Restricted:||||||||
|Fixed assets||reserve||4,106|||4,106|
|Capital reserve|||||2,533||2,533|
|General|||||2,914||2,914|
|Net assets||||19078|18996||38074|
|Charitable|company|||||||
|Unrestricted:||||||||
|Fixed assets||reserve||14,972|||14,972|
|Designated||strategic|reserves||6,486||6,486|
|Designated||building|reserves||3,050||3,050|
|General|||||3,988||3,988|
|Restricted:||||||||
|Fixed assets||reserve||4,106|||4,106|
|Capital reserve|||||2,533||2,533|
|General|||||2,914||2,914|
|Net assets||||19078|18971||38049|
|||||||Creditors||
|---|---|---|---|---|---|---|---|
||||||Net|over one||
|||||Fixed|current|year and|Total|
|||||assets|assets|rovisions|2020|
|||||f000|f000|f000|f000|
|Group||||||||
|Unrestricted:||||||||
|Fixed assets||reserve||15,746|||15,746|
|Designated||strategic|reserve||6,921||6,921|
|Designated||building|reserve||4,375||4,375|
|General|||||4,144|(36)|4,108|
|Restricted:||||||||
|Fixed assets||reserve||2,630|||2,630|
|Capital reserve|||||1,561||1,561|
|Net assets||||18376|17001|36|35341|
|Charitable|company|||||||
|Unrestricted:||||||||
|Fixed assets||reserve||15,739|||15,739|
|Designated||strategic|reserves||6,921||6,921|
|Designated||building|reserves||4,375||4,375|
|General|||||4,058|(36)|4,022|
|Restricted:||||||||
|Fixed assets||reserve||2,636|||2,636|
|Capital reserve|||||1,561||1,561|
|Net assets||||18375|16915|36|35254|
||Unrestricted|Unrestricted|Unrestricted|Unrestricted||Restricted||||
|---|---|---|---|---|---|---|---|---|---|
||fixed|designated||designated|Unrestricted|fixed|Restricted|Restricted|Total|
||assets|strate|ic|buildin|eneral|assets|eneral|ca ital|2021|
||f000|f000||f000|f000|f000|f000|f000|f000|
|Group||||||||||
|At 1 April 2020|15,746|6,921||4,375|4,108|2,630||1,561|35,341|
|Surplus for the year|||||152|1,845|736||2,733|
|Designated
reserve transfers||(807)||(1,325)|2,132|||||
|Depreciation
transfer|(824)|||||824||||
|Capital transfers|50||||171|(1,193)||972||
|Other transfers|||372||2,550||2,178|||
|At 31 March 2021|14972|6|486|3050|4013|4106|2914|2 533|38074|
|Charitable
company||||||||||
|At 1 April 2020|15,739|6,921||4,375|4,022|2,636||1,561|35,254|
|Surplus for the year|||||214|1,845|736||2,795|
|Designated
reserve transfers||(807)||(1,325)|2,132|||||
|Depreciation
transfer|(818)|||||818||||
|Capital transfers|51||||170|(1,193)||972||
|Other transfers|||372||2,550||2,178|||
|At 31 March 2021|14972|6|486|3050|3988|4106|2914|2 533|38049|
##
||Unrestricted|Unrestricted|Unrestricted||Restricted||||
|---|---|---|---|---|---|---|---|---|
||fixed|designated|designated|Unrestricted|fixed|Restricted||Total|
||assets|strate
ic|buiidin|enerai|assets|ca|ital|2020|
||f000|f000|f000|f000|f000|f000||6000|
|Group|||||||||
|At 1 April 2019|14,196|6,781|6,025|4,281|1,746|3,684||36,713|
|Deficit for the year||(1,239)||(539)|406||-|(1,372)|
|Designated
reserve transfers||1,300|(1,300)||||||
|Depreciation
transfer|(689)||||689||||
|Capital transfers|2,239|350|(350)|95|(211)|(2,123)|||
|Other transfers||271||271|||||
|At 31 March 2020|15,746|6,921|4,375|4,108|2,630|1,561||35341|
|Charitable
company|||||||||
|At 1 April 2019|14,189|6,781|6,025|4,120|1,752|3,684||36,551|
|Deficit for the year||(1,239)||(464)|406||-|(1,297)|
|Designated
reserve transfers||1,300|(1,300)||||||
|Depreciation
transfer|(689)||||689||||
|Capital transfers|2,239|350|(350)|95|(211)|(2,123)|||
|Other transfers||271||271|||||
|At 31 March 2020|15739|6921|4375|4 022|2636|1|561|35254|
##
|||||||Total|Total|
|---|---|---|---|---|---|---|---|
|Grou|and charitable||com an|||2021|2020|
|||||||FOOO|f000|
|Capital|commitments|at|the end of|the financial year for which no provision|has been made:|||
|Contracted||||||391|66|
|Amounts|due under|other operating||leases for plant and machinery:||||
|Within|one year|||||||
|Between one and||two|years|||||
|Between two and five|||ears|||||
##
##
##
##